About
Aristides Eliopoulos is Professor of Biology & Genetics and Head of the Department of Biology at the National & Kapodistrian University of Athens (NKUA), School of Medicine, where he leads research at the intersection of genetics, inflammation, and metabolic health. His work is at the forefront of precision medicine, leveraging AI to develop personalized therapeutic and nutritional strategies.
Beyond his prolific academic record—which includes five patents and a distinguished citation count—he has successfully bridged the gap between the lab and the market as co-founder and CSO of the genomics spin-off Genosophy®. He has coordinated multiple high-level National and EC-funded initiatives and remains a cornerstone of Greek medical education through his extensive teaching and textbook authorship.
Research
MASLD & liver pathologies
Investigating the molecular and genetic drivers of liver pathologies, with a focus on how autophagy and lipid pathways influence the progression of MASLD.
Therapeutic development
Developing innovative preventive and therapeutic strategies targeting metabolic disorders and malignant diseases.
Obesity & oncology
Mapping the molecular and genetic pathways that establish the causal links between obesity and cancer development.
AI & precision medicine
Integrating multimodal omics, lifestyle, and dietary data into AI platforms to advance precision medicine and personalized nutrition.
Lab members
Photos and full bios coming soon.
Aristides Eliopoulos
Thanassis Pseftogkas
Christina Simoglou Karali
Georgia Velimezi
Katerina Fyka
Ilias Papatzimas
Chloe Synacheri
Alumni
Details coming soon.
Publications
Selected highlights — full list on Google Scholar.
Teaching
Undergraduate courses
Biology & Genetics
1st & 2nd semester core courses, NKUA School of Medicine (330–370 students). Also taught in English in the International Medicine Programme (40 students). Course director and examiner.
Biology & applications of regenerative medicine
Undergraduate elective, NKUA School of Medicine (150–250 students). Lecturer, 2018–present.
Precision Medicine
Tutorials for 3rd/4th year medical students (250+ students), NKUA School of Medicine, 2018–present.
Graduate & doctoral training
Cancer Biology & Therapy
Module coordinator, Graduate Programme “Molecular Basis of Human Disease”, University of Crete Medical School, 2006–present.
Multiple MSc programmes
Tutorials across Immunology, Molecular Biomedicine, Infectious Diseases, Biotechnology, Human Neoplasia, NKUA, 2009–present. Supervisor of 30+ MSc projects.
PhD supervision / Διδακτορικές διατριβές
11 completed and 5 ongoing · 11 έχουν περατωθεί, 5 τρέχουσες
e-Learning & continuing education
Laboratory Genetics
Lecturer, 5-month e-Learning programme “Application and interpretation of genetic tests”, NKUA (5 cycles/year), 2021–present.
Books & textbook translations
Foundations of Biology for Medicine: A Problem-Based Approach
NKUA Press, 2026 — authored by Prof. Eliopoulos (forthcoming)
Textbook translations & editorial contributions
Alberts et al., Essential Cell Biology (used across Greek Medical Schools); Alberts et al., Molecular Biology of the Cell; Cooper, The Cell; Lodish et al., Molecular & Cellular Biology; Thompson & Thompson, Genetics and Genomics in Medicine; Strachan, Molecular Genetics; chapter “Molecular basis of malignancy” in Syrigos (ed.), Oncology.
Grants & funding
SYNTACTIC — Synthetic Data in Artificial Intelligence
Participant investigator. 3-year Horizon Europe collaborative research project on the use of synthetic data in AI platforms. (June 2026–2029)
Marie Skłodowska-Curie Postdoctoral Fellowship — Thanassis Pseftogkas
Investigation of the role of TPL2 kinase in lymphomas. €200,000 · Awarded to postdoctoral researcher T. Pseftogkas (Eliopoulos Lab). (May 2026–2028)
Among 1,650 successful proposals from 17,000+ worldwide applications; one of only 7 researchers with a Greek host institution funded in 2025.
HFRI Doctoral Fellowship — Chloe Synacheri
“Investigating molecular pathways, gene regulatory networks and cellular heterogeneity in disease through an integrated bioinformatics framework for multimodal next-generation sequencing data.” (2025–2027)
Research Excellence Partnerships — Malus domestica bioactive compounds
“Innovative Products from Bioactive Compounds of Apple (Malus domestica) for Improving Cardiometabolic Health.” Total budget: €1.2 million (2025–2026).
COST CA24124 — NeutroNARPS
“Network for the Advancement of Neutropenia Research and Patient Support” (OC-2024-1-27439). Proposal ranked in top 8.3% of all pan-European submissions. (2025–2028)
neutro-narps.eu →National Flagship Action — Infectious diseases of the lung
Co-scientific director. “Holistic molecular approach to mechanisms of immune injury in patients with severe pneumonia, aiming at the development of personalised biomarkers and innovative prognostic and prevention models.” Total budget: €4.7 million (2023–2025).
precision-medicine-cap.gr →For the public
Talks, interviews, articles and media appearances on science and health for general audiences.